Literature DB >> 16003466

Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.

John Sidney1, Scott Southwood, Alessandro Sette.   

Abstract

At the functional level, the majority of human leukocyte antigen (HLA) class I MHC variants can be classified into about ten different major groups, or supertypes, characterized by overlapping peptide binding motifs and repertoires. Previous studies have detailed the peptide binding specificity of the HLA A2, A3, B7, and B44 supertypes, and predicted, on the basis of MHC pocket structures, known motifs, or the sequence of T cell epitopes, the existence of the HLA A1 and A24 supertypes. Direct experimental validation of the A1 and A24 supertypes, however, has been lacking. In the current study, the peptide-binding repertoires and main anchor specificities of several common HLA A molecules (A*0101, A*2301, A*2402, A*2601, A*2902, and A*3002) predicted to be members of the A1 or A24 supertypes were analyzed and defined using single amino acid substituted peptides and a large peptide library. Based on the present findings, the A1 supertype includes A*0101, A*2601, A*2902, and A*3002, whereas the A24 supertype includes A*2301 and A*2402. Interestingly, A*2902 is associated with a motif and peptide binding repertoire that overlaps significantly with those of all of the A1- and A24-supertype molecules studied, representing-to our knowledge-the first report of significant cross-reactivity among molecules belonging to different supertypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16003466     DOI: 10.1007/s00251-005-0004-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  51 in total

1.  Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype.

Authors:  John Sidney; Scott Southwood; Valerie Pasquetto; Alessandro Sette
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

2.  Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.

Authors:  Scott R Burrows; Rebecca A Elkington; John J Miles; Katherine J Green; Susan Walker; Sofia M Haryana; Denis J Moss; Heather Dunckley; Jacqueline M Burrows; Rajiv Khanna
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

3.  Identifiying human MHC supertypes using bioinformatic methods.

Authors:  Irini A Doytchinova; Pingping Guan; Darren R Flower
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

4.  Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules.

Authors:  B D Livingston; C Crimi; J Fikes; R W Chesnut; J Sidney; A Sette
Journal:  Hum Immunol       Date:  1999-11       Impact factor: 2.850

5.  The HLA-A*0207 peptide binding repertoire is limited to a subset of the A*0201 repertoire.

Authors:  J Sidney; M F del Guercio; S Southwood; G Hermanson; A Maewal; E Appella; A Sette
Journal:  Hum Immunol       Date:  1997-11       Impact factor: 2.850

6.  Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules.

Authors:  J Sidney; H M Grey; S Southwood; E Celis; P A Wentworth; M F del Guercio; R T Kubo; R W Chesnut; A Sette
Journal:  Hum Immunol       Date:  1996-02       Impact factor: 2.850

7.  Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes.

Authors:  A Kondo; J Sidney; S Southwood; M F del Guercio; E Appella; H Sakamoto; H M Grey; E Celis; R W Chesnut; R T Kubo; A Sette
Journal:  Immunogenetics       Date:  1997       Impact factor: 2.846

8.  Molecular analysis of the serologically defined HLA-Aw19 antigens. A genetically distinct family of HLA-A antigens comprising A29, A31, A32, and Aw33, but probably not A30.

Authors:  K Kato; J A Trapani; J Allopenna; B Dupont; S Y Yang
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

9.  Peptide motifs of HLA-B58, B60, B61, and B62 molecules.

Authors:  K Falk; O Rötzschke; M Takiguchi; V Gnau; S Stevanović; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.

Authors:  K M Chang; N H Gruener; S Southwood; J Sidney; G R Pape; F V Chisari; A Sette
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

View more
  28 in total

1.  Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1*02601 and Mamu-B*08301 reveals HLA-A2 and HLA-A3 supertypic specificities.

Authors:  Scott Southwood; Christopher Solomon; Ilka Hoof; Richard Rudersdorf; John Sidney; Bjoern Peters; Angela Wahl; Oriana Hawkins; William Hildebrand; Bianca R Mothé; Alessandro Sette
Journal:  Immunogenetics       Date:  2011-01-28       Impact factor: 2.846

2.  Detailed characterization of the peptide binding specificity of five common Patr class I MHC molecules.

Authors:  John Sidney; Shinichi Asabe; Bjoern Peters; Kelly-Anne Purton; Josan Chung; Timothy J Pencille; Robert Purcell; Christopher M Walker; Francis V Chisari; Alessandro Sette
Journal:  Immunogenetics       Date:  2006-06-22       Impact factor: 2.846

3.  An asymmetric model of heterozygote advantage at major histocompatibility complex genes: degenerate pathogen recognition and intersection advantage.

Authors:  Rick J Stoffels; Hamish G Spencer
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

4.  Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.

Authors:  Masanori Terajima; Laura Orphin; Anita M Leporati; Pamela Pazoles; John Cruz; Alan L Rothman; Francis A Ennis
Journal:  Hum Immunol       Date:  2008-10-26       Impact factor: 2.850

Review 5.  Epitope prediction and identification- adaptive T cell responses in humans.

Authors:  John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Semin Immunol       Date:  2020-10-31       Impact factor: 11.130

6.  Host-specific adaptation of HIV-1 subtype B in the Japanese population.

Authors:  Takayuki Chikata; Jonathan M Carlson; Yoshiko Tamura; Mohamed Ali Borghan; Takuya Naruto; Masao Hashimoto; Hayato Murakoshi; Anh Q Le; Simon Mallal; Mina John; Hiroyuki Gatanaga; Shinichi Oka; Zabrina L Brumme; Masafumi Takiguchi
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

7.  Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.

Authors:  Arne Schneidewind; Mark A Brockman; John Sidney; Yaoyu E Wang; Huabiao Chen; Todd J Suscovich; Bin Li; Rahma I Adam; Rachel L Allgaier; Bianca R Mothé; Thomas Kuntzen; Cesar Oniangue-Ndza; Alicja Trocha; Xu G Yu; Christian Brander; Alessandro Sette; Bruce D Walker; Todd M Allen
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

8.  The most common Chinese rhesus macaque MHC class I molecule shares peptide binding repertoire with the HLA-B7 supertype.

Authors:  Christopher Solomon; Scott Southwood; Ilka Hoof; Richard Rudersdorf; Bjoern Peters; John Sidney; Clemencia Pinilla; Maria Cecilia Garibaldi Marcondes; Binhua Ling; Preston Marx; Alessandro Sette; Bianca R Mothé
Journal:  Immunogenetics       Date:  2010-05-18       Impact factor: 2.846

9.  Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.

Authors:  John T Loffredo; John Sidney; Alex T Bean; Dominic R Beal; Wilfried Bardet; Angela Wahl; Oriana E Hawkins; Shari Piaskowski; Nancy A Wilson; William H Hildebrand; David I Watkins; Alessandro Sette
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

10.  Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior.

Authors:  Yohan Kim; John Sidney; Clemencia Pinilla; Alessandro Sette; Bjoern Peters
Journal:  BMC Bioinformatics       Date:  2009-11-30       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.